Elekta Unity wins Silver Edison Award 2020

Published on: 8th April 2020

DCA is delighted to announce that Elekta’s next generation radiotherapy system has been recognised with a Silver Edison award for radiation treatment advancements.

Named after Thomas Edison, whose extraordinary new product development methods made him a household name across the world, the Edison Awards have recognised and honoured some of the most innovative products and business leaders in the world since they were established in 1987. An Edison award is among the most prestigious accolades honouring excellence in new product and service development, marketing, design and innovation, and this year Elekta Unity has been chosen as a winner by a panel of over 3,000 leading business executives from around the world.

“After a thorough review, the Edison Awards Judges recognize Elekta Unity as a game changing innovation standing out among the best new products and services launched in their category,” said Frank Bonafilia, Executive Director of the Edison Awards.

“Elekta Unity is indeed a paradigm shift for precision radiation medicine,” said Richard Hausmann, Elekta’s President and CEO. “And we are very happy to receive this recognition for our efforts in making the technology available to people living with cancer all around the world. Unity’s breakthrough technology is designed to provide the best outcomes for patients while meeting the needs of the cancer care team delivering treatment, fully in the spirit of Edison, a truly breakthrough inventor.”

Malcolm Boyd, Senior Sector Manager at DCA commented, “Being selected as a nominee for such a prestigious award is a celebration in itself, but to be presented with a Silver award makes us massively proud to have been part of delivering this important system. This award, in conjunction with the many other awards Unity has won, recognises the game changing innovation that it brings to the global battle against cancer that sadly impacts so many of us. Well done to everyone involved for offering a new hope to cancer patients of the future.”